Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Eptifibatide in Aspirin or Clopidogrel Resistant Patients Undergoing PCI
NCT00289601Phase 4Terminated
- Sponsor
- Brigham and Women's Hospital
- Start
- Mar 2006
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of eptifibatide in coronary artery disease (CAD), sponsored by Brigham and Women's Hospital. Started Mar 2006; status: terminated.
02
Drugs
eptifibatide
03
Conditions
coronary artery disease (CAD)
Beyond the preview
Go deeper on NCT00289601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00289601.